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We congratulate he authors on their meticulous analy- 
sis of all cases reported in the literature. We hope that this 
letter may stimulate further multidisciplinary discussion. 
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Reply 
The comments of F. M. Vanhoenacker t al are noted 
with interest. As they correctly point out, there are sever- 
al well-established theories regarding the pathogenesis of
adventitial cystic disease, each with its own protagonists. 
They have summarized some of the evidence in favor of 
the synovial theory and have stressed the significance of 
demonstrating ananatomic ommunication with the rele- 
vant adjacent joint to support heir argument. 
However, histochemistry of the cyst lining has failed to 
demonstrate convincingly a synovial origin for these cells, 
and detailed chemical analysis of adventitial cyst fluid 
demonstrates gross chemical differences of many of the 
fluid constituents when compared with those of synovial 
fluid. 
The correspondents have used as support of the syn- 
ovial theory the age of patients presenting with this enig- 
matic disease, but they fail to mention that this condition 
has been reported in school-aged children. There must 
therefore remain a considerable element of doubt when 
considering the synovial theory. 
In our publication we have drawn attention to the fact 
that all reported adventitial cystic disease occurs in nona~xial 
arteries. This does not constitute proof of the embryological 
theory, but simply lends support o this latter theory. 
It is a dramatic experience to incise an adventitial cyst 
and be treated to the vision of crystal-clear fluid emerging 
from the vessel. The tantalizing macroscopic similarity of 
the adventltial cyst to a simple ganglion and the demon- 
stration of an anatomic ommunication cannot constitute 
absolute proof of the ganglion theory. More definitive 
data about this curious condition are required before this 
argument can be laid to rest. 
Lewis J. Levien, FCS, PhD 
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Regarding "Randomized study of  carotid angioplasty 
and stenting versus carotid endarterectomy: a 
stopped trial" 
To the Editors: 
Naylor and colleagues 1 report the results of a "ran- 
domized study" comparing carotid angioplasty-stenting 
(CAS) and carotid endarterectomy (CEA) in the manage- 
ment of symptomatic extracranial carotid stenosis. These 
investigators andomized 17 patients (10 to CEA and 7 to 
CAS) in a study that presumably was intended to random- 
ize 300 patients but was terminated because of unaccept- 
able results in the CAS group. Although we applaud the 
Leicester group's interest in proceeding with a clinical 
trial, our first observation is their apparent misunder- 
standing of the methodology in selecting a small sample 
size of only 300 patients, which we regard as inadequate 
to answer this question. The CREST (Carotid Revascu- 
latization Endarterectomy vs Stent Trial) investigators, 2 
recently funded by a grant from the National Institute for 
Neurological Disorders and Stroke, National Institutes of 
Health, have planned for a sample size of 2500 sympto- 
matic patients to determine clinical efficacy for these two 
procedures. Furthermore, the safety considerations insti- 
tuted by Naylor and colleagues were unacceptable in our 
opinion. We seek to reassure clinicians in North America 
and Europe who have xpressed interest in participation i
CREST that no matter how sldlled an interventionalist 
might be in the peripheral or coronary circulations, ran- 
domization of cases will not proceed until the interven- 
tionalist has attended a Carotid Stent Operators' 
Certification Program and has performed required preran- 
domization run-in procedures. Results will be reviewed by 
the Interventional Management Committee using prede- 
fined established criteria before randomization ofcases can 
be initiated. During the performance of these cases or sub- 
sequently during the trial, one major complication (stroke 
or death) wilt result in a "watch status" for the institution, 
and a second major complication requires a site visit from 
the Surgical Management Committee, if it occurs with 
CEA, or from the Interventional Management Corn- 
